Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Fontana D, Malighetti F, Villa M, Zambon A, et al. Leukemia 2024;38:1843-1847.

Read + Share

Amedeo Smart

Independent Medical Education

Fontana D, Malighetti F, Villa M, Zambon A, et al. Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. Leukemia 2024;38:1843-1847.
PMID: 38750137